Pathways to commercialization Learn and get support right here!
Commercialization training and support resources for you!
the campus of UF Scripps Biomedical Research located in Jupiter, Florida, is pictured against a sunsetting, nearly cloudless sky of pinks, oranges, yellows, and blues. We look forward to working with you!
Your portal to innovation is ready for you.

Welcome, UF Scripps Biomedical Researchers

a group celebrates as they climb a mountain successfully You can celebrate success with us!
Accelerate your path to success at Sid Martin Biotech & The Hub

Accelerate: A new name for our incubators

more portal magic for you MTAs for everyone!
High-quality, expedited service for UF and outside researchers alike
portal magic
Use it to tell us about your discoveries 24-7
COVID-19 images
UF technologies & small companies make a big difference
the intersection of wall street and the university of florida
Connecting UF startups to growth opportunities & capital
innovation navigator logo on a background depicting a light bulb shedding light on wood
Uniting North Central Florida entrepreneurs for the benefit of all

Our Mission

UF Innovate is building business on innovation. It is the umbrella organization uniting the four entities that drive the innovation ecosystem at UF. Based at one of the nation’s leading research institutions, UF Innovate comprises Tech Licensing, Ventures, Pathways, and an Accelerate program, which includes two business incubators, The Hub and Sid Martin Biotech. Together, those organizations move research discoveries from the laboratory to the market. UF Innovate connects innovators with entrepreneurs, investors and industry, incubates startups and growth companies, and fosters a resilient economy — all in an effort to make the world a better place.


For UF Innovators

Explore the licensing process, common questions and available resources, and learn what it’s like to work with Tech Licensing. 


For Entrepreneurs

Interested in starting a company? See our startups, learn about funding and don’t underestimate the power of a business incubator.


Search Technologies

Drill down in our database for the technologies that interest you most & sign up for tech alerts so you’ll be first to know.

UF Innovate By The Numbers

Snapshot of Our Innovation Ecosystem
$10.4B+
Generated in Private Investment
200+
Startups Launched by Tech Licensing
7,900+
Jobs Created with Startups

Startup News

Alcyone Presents Preclinical Data on Gene Therapy Programs With the Center for Gene Therapy at the Abigail Wexner Research Institute (AWRI) at ASGCT 2022

Sid Martin Client Alcyone Therapeutics Inc. ("Alcyone"), a biotechnology company pioneering next-generation precision gene-based therapies for complex neurological conditions, presented preclinical data showing the Company's partnered novel adeno associated virus serotype 9 (AAV9) gene therapy vector ACTX-101 safely and effectively reactivates the inactive X chromosome in a Rett syndrome mouse model and is safe in a preliminary nonhuman primate study at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting.

AGTC Announces Positive Three-Month Interim Results From Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa

UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, today reported positive three-month interim data from its ongoing Phase 2 Skyline trial of AGTC-501, a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene in patients with X-linked retinitis pigmentosa (XLRP).
X